baber/WOPTO huggingface dataset:
Patent MX-2019005164-A (MX)
Title: Filter elements, air cleaner assemblies, and methods of use and assembly.
Inventor: KRISTOF DECOSTER
IPC: B01D46/24
Filed: 2017-11-03
Abstract: Air cleaner assemblies, components, and features are described. The features can be used to provide that the air cleaner assembly (1) includes a housing (2) and cover (50) within which primary (100) and secondary (200) filter cartridges, having a media pack and a seal arrangement surrounding the media pack, can be installed. The filter cartridges can include an open end cap with an axially deviating seal arrangement and a plurality of axially extending channels for engaging with ribs on the housing. The filter cartridges can also include extension members extending from the open end cap that include the axially extending channels, entirely or partially. The filter cartridges can also include a guide member extending from the extension members for providing a low friction surface against the housing during installation that allows axial force exerted by the installer to be translated into a rotational force that rotates the filter cartridge during installation.
Patent MX-2019005179-A (MX)
Title: Short physical downlink control channel (spdcch) mapping design.
Inventor: NIKLAS ANDGART
IPC: H04L5/00
Filed: 2017-11-03
Abstract: A method, network node and wireless device for mapping a short physical downlink control channel, sPDCCH, to resource elements of a time-frequency grid to achieve one of high frequency diversity and condensed frequency allocation are provided. According to one aspect, a method includes determining available time-frequency resources to be configured as short resource element groups, sREGs, configuring sREGs within a physical resource block, PRB, to map the sPDDCH to the resource elements. The number of sREGs depend upon a number of orthogonal frequency division multiplex, OFDM, symbols of the sPDCCH. Each sREG spans one OFDM symbol.
Patent MX-2019005775-A (MX)
Title: Pharmaceutical parenteral formulation containing carglumic acid.
Inventor: FABIO BERLATI
IPC: A61K9/19
Filed: 2017-11-20
Abstract: The present invention relates to a pharmaceutical formulation suitable for parenteral administration containing carglumic acid and a buffering agent having a pKa from 5.5 to 9.0 at 25 °C; according to an embodiment, the buffering agent may have a pKa from 7.5 to 8.5, preferably a pKa of about 8.07, such as trometamol. The formulation may also contain at least one bulking agent, such as mannitol. The invention also includes a method for manufacturing a lyophilised sterile formulation by freeze-drying a water solution containing carglumic acid, a buffering agent having a pKa from 5.5 to 9.0 at 25 °C, preferably from 7.5 to 8.5, and optionally a bulking agent to obtain a freeze-dried powder.
Patent MX-2019005831-A (MX)
Title: Aptamers for use in inhibition and/or suppression of tlr9 activation.
Inventor: ANNEKATHRIN HABERLAND
IPC: A61P29/00
Filed: 2017-10-27
Abstract: The present invention relates to new aptamer molecules for use in therapy of a subject by inhibiting or suppressing the activation of TLR9 in a cell, a method of inhibiting or suppressing the activation of TLR9 in a cell using such aptamer molecules, a pharmaceutical composition and a kit comprising such aptamer molecules and the use of aptamer molecules for inhibiting or suppressing TLR9 activation.
Patent MX-2019005832-A (MX)
Title: Coolant for cooling systems in electric vehicles having fuel cells and/or batteries containing azole derivatives and additional corrosion protectants.
Inventor: HARALD DIETL
IPC: H01M8/04
Filed: 2017-11-14
Abstract: The present invention relates to coolants for cooling systems in electric vehicles having fuel cells and/or batteries, preferably for motor vehicles, particularly preferably for passenger and commercial vehicles (so-called light and heavy duty vehicles), based on alkylene glycols or derivatives thereof containing not only special azole derivatives but also additional corrosion inhibitors for improved corrosion protection.
Patent MX-2019005951-A (MX)
Title: A method of producing a food or beverage product with free divalent cations protein aggregation.
Inventor: ERIC STANISLAS KOLODZIEJCZYK
IPC: A23J3/08
Filed: 2017-12-18
Abstract: The invention relates to a method of producing a food or beverage product, comprising the steps of: providing an ingredient composition comprising, micellar caseins and whey proteins and having a pH of 6.1 - 7.1 and a concentration of 1 - 15 wt.% of proteins, and wherein the ingredient composition has a casein to whey protein ratio of 90/10 - 60/40,adding 3 - 25 mM divalent cations to provide a concentration of 3 - 8 mM free divalent cations in the ingredient composition, homogenising the ingredient composition; and subsequently pasteurising and stirring the ingredient composition at a temperature of 80°- 100°C for a period of 0.5 - 3 min to form agglomerated proteins comprising caseins and beta-lactoglobulin from the whey proteins, the agglomerates having a size of 5 - 50 microns as measured by D(4, 3) mean diameter. The invention relates also to a food or beverage product comprising aggregated proteins comprising micellar casein and whey protein aggregates, wherein the product has a pH of 6.1 - 7.1, a concentration of 6 - 40 wt.% milk solids, a casein to whey protein ratio of 90/10 - 60/40, and a concentration of 3 - 8 mM free divalent cations, and wherein the agglomerates having a size of 5 - 50 microns mean diameter D(4, 3) as measured by laser diffraction.
Patent MX-2019006370-A (MX)
Title: Autonomous vehicle with secondary camera system for use with encountered events during travel.
Inventor: Donald R High
IPC: B60W30/08
Filed: 2017-12-01
Abstract: In some embodiments, apparatuses and methods are provided herein useful to monitoring an event encountered by an autonomous vehicle. In some embodiments, an autonomous vehicle for monitoring an encountered event comprises a vehicle body, a propulsion mechanism, a plurality of sensors configured to detect travel information, a primary camera system affixed to the vehicle body, a secondary camera system including two or more cameras, wherein each of the two or more camera has a different fixed field of view, and wherein each of the two or more cameras are affixed to different portions of the vehicle body, and a control circuit, the control circuit configured to receive, from the plurality of sensors, the travel information, determine, based on the travel information, that a trigger condition has occurred, and in response to a determination that the trigger condition has occurred, cause video captured by the secondary camera system to be stored.
Patent MX-2019006437-A (MX)
Title: Compositions for modulating pd-1 signal transduction.
Inventor: Samir KHLEIF
IPC: C07D235/02
Filed: 2017-12-01
Abstract: Several compounds have been discovered that modulate signal transduction through the PD-1 receptor. In certain embodiments, the compounds promote or induce an activating signal through the PD-1 receptor that activates a T cell. The compounds can bind to PD-1 and inhibit or prevent ligands from binding to PD-1 and thereby suppress inhibitory signal transduction through the PD-1 receptor.
Patent MX-2019007752-A (MX)
Title: Contact tray having picketed liquid flow barriers and method involving same.
Inventor: IZAK NIEUWOUDT
IPC: B01D3/16
Filed: 2017-12-27
Abstract: A contact tray for use in a mass transfer or heat exchange column and having a tray deck with an inlet area and a remotely positioned outlet for respectively receiving liquid on the tray deck and then removing the liquid after it has flowed across the tray deck and interacted with another fluid on and above the tray deck. A plurality of barriers are positioned between the inlet area and the outlet. The barriers each have spaced-apart pickets and openings in the spacing between adjacent ones of the pickets. The pickets impede the flow of the liquid and increase the upstream liquid loading on the tray deck as the liquid flows from the inlet area, through the openings, and then into the outlet. At low liquid flow rates, this increase in the liquid loading may significantly increase the vapor handling capacity of the tray.
Patent MX-2019008246-A (MX)
Title: Button assembly with removable cap.
Inventor: CHUCK G LECOMPTE
IPC: F16B11/00
Filed: 2019-07-09
Abstract: A button assembly includes a top assembly, an attachment body, and a resilient member. The top assembly includes a cap and a locking ring defining a receiving area, and the locking ring includes a top protrusion extending into the receiving area. The attachment body includes a locking feature that includes a body protrusion and a notched portion. The resilient member is located between the cap and the attachment body such that the cap is movable toward the attachment body. In some examples, the top assembly is selectively engageable with the attachment body by aligning the top protrusion of the locking ring with the notched portion of the locking feature, pushing the top assembly toward the attachment body, and rotating the top assembly relative to the attachment body such that the top protrusion of the locking ring is aligned with the body protrusion of the locking feature.
Patent MX-2019008453-A (MX)
Title: Zwitterionic imidazolinium surfactant and use in the manufacture of absorbent paper.
Inventor: YU CHEN
IPC: D21H17/07
Filed: 2018-01-10
Abstract: Zwitterionic surfactant compounds and their use in connection with absorbent paper manufacture in debonder and softener formulations. An exemplary surfactant is an imidazolinium compound of formula: wherein X is SO3, R1 is a hydrocarbyl spacer group having a chain length of from 2-6 carbon atoms, R2 is a hydrocarbyl group having from 8 to 22 carbon atoms; and R3 is an alkenylamidoalkyl moiety having from 8 to 30 carbon atoms.
Patent MX-2019009722-A (MX)
Title: Retainer systems for ground engaging tools.
Inventor: JAMES R LAHOOD
IPC: E02F9/28
Filed: 2015-11-24
Abstract: Disclosed are various exemplary embodiments of a retainer system for a ground engaging tool. In one exemplary embodiment, the retainer system may include a lock having a lock rotation axis and including an outer surface extending about the lock rotation axis. The retainer system may also include a retainer bushing including an inner surface extending about the lock rotation axis, where the inner surface is configured to rotatably receive the outer surface of the lock. The outer surface of the lock and the inner surface of the retainer bushing may be aligned substantially parallel to the lock rotation axis.
Patent MX-2019011562-A (MX)
Title: Catheter insertion-tray systems and methods thereof.
Inventor: JOHN GOHDE
IPC: B65D1/36
Filed: 2018-03-29
Abstract: A catheterization package including a catheterization tray and contents for a catheterization procedure. The catheterization tray can include a structural configuration for maintaining a sterile field about a patient throughout the catheterization procedure, the sterile field including at least a portion of the tray. The structural configuration of the tray can provide a sterile side of the tray designated for a first person performing sterile steps of the catheterization procedure in the sterile field. The structural configuration of the tray can also provide a non-sterile side of the tray designated for either the first person or a second person performing non-sterile steps of the catheterization procedure outside the sterile field. The contents for the catheterization procedure can include a perineal care kit, two or more pairs of gloves, and a drainage system including a catheter.
Patent MX-2020001155-A (MX)
Title: Surface modified calcium carbonate containing minerals and its use.
Inventor: JOACHIM SCHOELKOPF
IPC: C09D7/62
Filed: 2015-01-09
Abstract: The present invention is related to ball-shaped spherical surface modified spherical calcium carbonate comprising minerals, the process for preparing such ball-shaped spherical surface modified spherical calcium carbonate comprising minerals, and their use.
Patent MX-2020002344-A (MX)
Title: Dual pump group with mechanical drive comprising a centrifugal clutch.
Inventor: PEDERSOLI MARCO
IPC: F01P5/12
Filed: 2018-06-21
Abstract: A pump group (1) for a cooling system of an engine of a vehicle, of the dual type. The pump group (1) comprises an impeller (3) mounted on a shaft (2) that is commandable in rotation by an electric drive (5) and a mechanical drive (10). Said mechanical drive (10) comprises: a rotating member (11), that is commandable in rotation by mechanical movement means comprised in the vehicle; a rotary drum (12), operatively connected to the shaft (2); a centrifugal clutch device (15) comprising: m) a central body (151) integrally attached to the rotating member (11); n) a plurality of engagement elements (152) movably fixed on the central body (151) suitable to translate in a radial direction with respect to the axis (X-X) to engage the rotary drum (12).
Patent MX-2020002347-A (MX)
Title: Use of physiological cooling active ingredients, and compositions comprising such active ingredients.
Inventor: WEISEL MARTIN
IPC: A23L33/10
Filed: 2018-08-31
Abstract: The invention primarily relates to methods for the modulation, preferably for the <i>in vitro</i> and/or <i>in vivo</i> modulation, of the cold and menthol receptor TRPM8, wherein the receptor is brought into contact with at least one modulator which is selected from the group consisting of the compounds of structural type 1 described herein. The present invention also relates to corresponding uses and compositions comprising such compounds.
Patent MX-2020004420-A (MX)
Title: Protease-cleavage resistant, shiga toxin a subunit effector polypeptides and cell-targeted molecules comprising the same.
Inventor: POMA ERIC
IPC: C07K14/245
Filed: 2016-12-08
Abstract: The present invention provides protease-cleavage resistant molecules comprising Shiga toxin effector polypeptides capable of exhibiting potent, Shiga toxin functions (<i>e.g</i>. subcellular routing and cytotoxicity). The present invention also provides protease-cleavage resistant, cell-targeted molecules for targeting specific cell types, <i>e.g</i>., infected or malignant cells. Certain molecules of present invention are cytotoxic, and certain cell-targeted molecules of present invention may be used for the targeted killing of specific cell types and treatment of a variety of diseases, disorders, and conditions, including cancers, tumors, growth abnormalities, immune disorders, and microbial infections. Certain cell-targeted molecules of the invention exhibit improved, in vivo tolerability as compared to related cell-targeted molecules comprising protease-cleavage sensitive, wild-type, Shiga toxin effector polypeptides. The cell-targeted molecules of the invention can deliver additional materials, such as, <i>e.g</i>., antigens, cytotoxic agents, and detection-promoting agents, into interiors of target cells.
Patent MX-2020005341-A (MX)
Title: Substituted azacycles as muscarinic m1 receptor positive allosteric modulators.
Inventor: NIROGI RAMAKRISHNA
IPC: A61P25/00
Filed: 2018-11-21
Abstract: The present invention relates to compounds of formula (I), or their isotopic forms, stereoisomers, tautomers or pharmaceutically acceptable salt (s) thereof as muscarinic M1 receptor positive allosteric modulators (M1 PAMs). The present invention describes the methods of preparation, pharmaceutical composition, combinations and the use of compound formula (I), their stereoisomers, isotopic forms or pharmaceutically acceptable salts thereof. (I).
Patent MX-2020005392-A (MX)
Title: N4-hydroxycytidine and derivatives and anti-viral uses related thereto.
Inventor: PAINTER GEORGE R
IPC: A61K31/7064
Filed: 2018-12-07
Abstract: This disclosure relates to certain N4-hydroxycytidine derivatives, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of viral infections, such as Eastern, Western, and Venezuelan Equine Encephalitis (EEE, WEE and VEE, respectively), Chikungunya fever (CHIK), Ebola, Influenza, RSV, and Zika virus infection with the disclosed compounds.
Patent MX-2020005658-A (MX)
Title: Albumin-binding prodrugs of auristatin e derivatives.
Inventor: KRATZ FELIX
IPC: C07K5/02
Filed: 2018-11-30
Abstract: The present disclosure provides for albumin-binding prodrugs of auristatin E derivatives and uses thereof.
Patent MX-2020006589-A (MX)
Title: Geminivirus resistant plants.
Inventor: VAN ENCKEVORT LEONORA JOHANNA GERTRUDA
IPC: C12N15/82
Filed: 2018-12-21
Abstract: The current invention pertains to a dicot plant cell, plant tissue or plant having a reduced expression of a wild type protein having at least 75% sequence identity with SEQ ID NO. 1. Furthermore, the invention pertains to a plant cell, plant tissue or plant comprising a modified protein and/or a truncated protein having at least about 75% sequence identity when calculated over the positions corresponding to positions 1 -66 and positions 78 -308 of SEQ ID NO: 1 and wherein the modified protein increases the resistance to Geminiviridae as compared to an otherwise identical plant cell, plant tissue or plant expressing the protein without the modification or without the truncation. The invention further pertains to nucleic acid constructs encoding the modified or truncated protein. In addition, the invention relates to methods for generating a plant cell, plant tissue or plant comprising the modified protein that increases the resistance to Geminiviridae.Furthermore, the invention pertains to a plant cell, plant tissue or plant obtainable by the method of the invention.
Patent MX-2020010515-A (MX)
Title: Image prediction method and related device.
Inventor: LIN SIXIN
IPC: H04N19/513
Filed: 2017-09-08
Abstract: An image prediction method and related device. The image prediction method comprises: determining two pixel samples in a current image block, and determining a unit set of candidate motion information corresponding to each of the two pixel samples; determining a unit set i which combines motion information and comprises two motion information units; and predict a pixel value of the current image block using an affine motion model and the unit set I which combines the motion information. The technical solution provided in the embodiment of the present invention reduces calculation complexity of the image prediction based on the affine motion model.
Patent MX-2020013098-A (MX)
Title: Smart valved holding chamber.
Inventor: NOWAK BART
IPC: A61M15/00
Filed: 2019-06-03
Abstract: A medication delivery system including a holding chamber having an input and an output end, a backpiece coupled to the input end of the holding chamber and having an electrical circuit and an opening. An MDI incudes an insert portion moveable between an engaged position wherein the insert portion is received in the opening and a disengaged position wherein the insert portion is removed from the opening, and at least one contact that completes the electrical circuit when the insert portion is in the engaged position.
Patent MX-2020013715-A (MX)
Title: Heat-shrinkable multilayer film and heat-shrinkable label.
Inventor: OHNO NAOKI
IPC: G09F3/04
Filed: 2019-06-10
Abstract: The present invention provides a heat-shrinkable multilayer film, and a heat-shrinkable label having the heat-shrinkable multilayer film as a base film, wherein wrinkling or slackening of the label following attachment can be prevented when the label is attached to a container as a heat-shrinkable label for dry heat shrinkage. The present invention pertains to a heat-shrinkable multilayer film having: front and back layers containing a polyester-based resin; and an intermediate layer containing a polystyrene-based resin, wherein the dimensional change of the film in the TD direction as represented by equation (1) is -55 to -1000 Î¼m, as measured by a thermomechanical analysis (TMA) in which the film is heated from 30Â°C to 60Â°C at a heating rate of 5Â°C/min and cooled from 60Â°C to 10Â°C at a cooling rate of 5Â°C/min while applying a load of 0.10 N. (1): Dimensional change = dimension in the TD direction at 20Â°C - dimension in the TD direction at 60Â°C.
Patent MX-2020014244-A (MX)
Title: Terephthalic acid esters formation.
Inventor: ESSADDAM ADEL
IPC: C07C67/03
Filed: 2019-06-24
Abstract: The present disclosure relates to the formation of dimethyl terephthalate (DMT). The present invention also relates to the depolymerization of polyethylene terephthalate (PET) and the recovery of dimethyl terephthalate (DMT).
Patent MX-2021003040-A (MX)
Title: Animal feed compositions and uses thereof.
Inventor: LOPEZ-ULIBARRI RUAL
IPC: A23K10/30
Filed: 2019-09-17
Abstract: The present invention relates to a composition and/or an animal feed comprising polypeptides having muramidase activity and essential oils and uses thereof.
Patent MX-2021003903-A (MX)
Title: Combination therapy for melanoma.
Inventor: MAURER MATTHEW
IPC: A61K39/395
Filed: 2019-10-18
Abstract: The invention provides a method of treating a previously untreated metastatic or unresectable melanoma.
Patent MX-2021004623-A (MX)
Title: Alkenyl succinimides and use as natural gas hydrate inhibitors.
Inventor: LAURENT BOYD ANTHONY
IPC: C09K8/524
Filed: 2019-10-28
Abstract: Disclosed are succinimide-based compounds used in compositions and methods for inhibiting natural gas hydrate agglomerates. The succinimide-based compounds are reaction products of an alkenyl succinic anhydride and an amine or amine alcohol.
Patent MX-2021005424-A (MX)
Title: Crystalline forms of a substituted imidazopyridine compound and use thereof as p2x3 modulator.
Inventor: GARCEAU DENIS
IPC: C07D471/04
Filed: 2019-11-12
Abstract: Described herein are crystalline forms of a P2X3 modulator, namely (S)-methyl-2-((2-(2,6-difluoro-4-(methylcarbamoyl)phenyl)-7- methylimidazo[l,2-a]pyridin-3-yl)methyl)morpholine-4-carboxylate or a solvate thereof, and use thereof for treating pain, urinary tract disorder, cough, pruritus and endometriosis.Described herein are crystalline forms of a P2X3 modulator, namely (S)-methyl-2-((2-(2,6-difluoro-4-(methylcarbamoyl)phenyl)-7- methylimidazo[l,2-a]pyridin-3-yl)methyl)morpholine-4-carboxylate or a solvate thereof, and use thereof for treating pain, urinary tract disorder, cough, pruritus and endometriosis. Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a viral population in an animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a viral population in an animal.
Patent MX-2021008958-A (MX)
Title: Anti-il2 receptor gamma antigen-binding proteins.
Inventor: ORENGO JAMIE M
IPC: A61P37/06
Filed: 2020-01-30
Abstract: The present invention provides antibodies and antigen-binding fragments (<i>e.g</i>., human antibodies) that bind specifically to human IL2 receptor gamma (IL2RÎ³). Methods for treating or preventing diseases mediated by IL2RÎ³ (<i>e.g</i>., graft vs host disease) using the antibodies and fragments are also provided along with methods of making the antibodies and fragments.
Patent MX-2021009811-A (MX)
Title: Transceiver device and scheduling device.
Inventor: SUZUKI HIDETOSHI
IPC: H04L5/00
Filed: 2020-01-24
Abstract: The present disclosure provides a transceiver device and scheduling device, and communication methods for transceiver device and scheduling device. The transceiver device comprises a transceiver which, in operation, receives, over a physical downlink control channel (PDCCH), a sub-band occupancy indicator indicating sub-bands determined to be available for a transmission, and a resource allocation indicator indicating resources included in the available sub-bands and assigned to the transceiver device for the transmission; and circuitry which, in operation, determines the assigned resources according to the resource allocation indicator and the sub-band occupancy indicator.